Modapil, Mohadjer .
HRN: 23-35-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2023
07/23/2023
IVT
23mg
Od
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes